Supplementary
A, MV and Exo were isolated from the same donor and resuspended in the same volume of PBS. Size distribution of EV samples was measured by nanoparticle tracking analysis (NTA) at a dilution of 1:33. B-E, Peripheral blood was drawn from each of five donors into two tubes containing EDTA and two tubes containing Li-Heparinate (Li-Hep, 16 I.E./ml blood). MV were isolated and analyzed by NTA. Shown is one representative overlay of MV from one donor (B) and the summary of all analyzed MV samples (C, n=3, mean±SD). MV protein yield (D) was determined (line=median) and standard markers assessed by flow cytometry (E, mean±SD, n=3-5). Samples from the same donor are marked in the same color. F+G, EDTA-anticoagulated blood was collected from six donors and plasma samples were divided by two. One half was directly subjected to MV isolation, the other half was stored for ≤2 weeks at -20°C and then used for MV isolation. EV yields were determined by quantification of total protein (F, line at median) and obtained MV analyzed by flow cytometry (G, mean±SD, n=6, *p<0.05). H+I, EDTA-anticoagulated plasma samples from 14 donors were divided by two and stored at -20°C for either 2 weeks (2 wk) or 6 months (6 mo) before isolating MV. Total MV protein was quantified (H, line at median) and MV further characterized by flow cytometry (I, mean±SD, n=10). 
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